Cancer, Diagnostic, Lung Diseases, News Home, Stanford Scope.
injected into a human — and it’s subjected to near the same scrutiny as any new drug,” he said. The trial included patients who were healthy (the controls) and those who were known to have one of the diseases (cancer or IPF). Although it was small — just a handful of patients from Stanford and